Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Carcinoma | MicrobiomeTrials← Back to trialsNCT07638436
Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06-17Est. Completion: 2028-01-01
Enrollment target: 42 participants Locations- No. 651 Dongfeng East Road, Guangzhou, Guangzhou, Guangdong, China
Other microbiome trials you might be interested in
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
This is a study for people with locally advanced or metastatic cancer for whom previous treatment was not successful. Ad…
Seoul, South KoreaEst. completion Jun 2027
Esophageal Squamous Cell Carcinoma
This is a Phase III, multicenter, open-label, randomized controlled trial. The study aims to compare organ preservation …
Multiple LocationsEst. completion Mar 15, 2032